Skip to main content
OpenTrials

Clinical trial condition

Hemophilia B With Inhibitor

Explore clinical trials studying Hemophilia B With Inhibitor. Study availability and eligibility vary by location and protocol.

10 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Hemophilia B With Inhibitor trial results

Recruiting

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

NCT04647227

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Center for Bleeding Disorders Little Rock, Arkansas, United States
  • Orthopaedic Institute for Children Los Angeles, California, United States
  • University of California at Davis UC Davis Hemostasis and Thrombosis Center Sacramento, California, United States
View all 21 locations
View Trial Details
Completed

ATHN 7: Hemophilia Natural History Study

NCT03619863

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital Phoenix, Arizona, United States
  • Orthopaedic Institute for Children HTC Los Angeles, California, United States
  • Orthopedic Institute for Children Hemophilia Program Los Angeles, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
View all 29 locations
View Trial Details
Completed

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

NCT06010953

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • Anhui Provincial Hospital Hefei, China
  • The First Affiliated Hospital of Shandong First Medical University Jinan, China
  • The Second Affiliated Hospital of Kunming Medical University Kunming, China
  • Jiangxi Provincial People's Hospital Nanchang, China
View Trial Details
Completed

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

NCT05651061

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Henan Provincial Cancer Hospital Zhengzhou, Henan, China
  • Xiangya Hospital, Central South University Changsha, Hunan, China
  • Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
View Trial Details
Completed

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

NCT03818529

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +14 more
Locations
  • Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital Phoenix, Arizona, United States
  • Valley Children's Hospital Madera, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • UCSF Pediatric Hemophilia Treatment Center at Mission Bay San Francisco, California, United States
View all 27 locations
View Trial Details
Completed

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

NCT03407651

Conditions
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Locations
  • Hematology Center after Prof. R. Yeolyan Yerevan, Armenia
  • JSC "K.Eristavi National Center of Experimental and Clinical Surgery" Tbilisi, Georgia
  • LTD M.Zodelava Hematology Centre Tbilisi, Georgia
  • LTD Medinvest - Institute of Hematology and Transfusiology Tbilisi, Georgia
View Trial Details
Completed

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

NCT04072237

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Medical Center "Hippocrates - N" Plovdiv, Bulgaria
  • Specialized Hospital for Active Treatment of Hematological Diseases Sofia, Bulgaria
  • Kirov Research Institute of Hematology and Blood Transfusion Kirov, Russia
  • National Medical Hematology Research Center Moscow, Russia
View Trial Details

Related conditions